HIV Medications for HIV Prevention
Basics
 San Fran Very Close to Becoming First City to Pass Out PrEP (September 8, 2011)
From The Body
- Preparing for PrEP, Part 1: What Pre-Exposure Prophylaxis Could Mean for Black Gay and Bi Men (March 22, 2011)
From Black AIDS Institute
- CDC Trials: Pre-Exposure Prophylaxis for HIV Prevention (February 2011)
To read PDF, click here.
From U.S. Centers for Disease Control and Prevention
- Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: Promoting Safe and Effective Use in the United States (February 2011)
To read PDF, click here.
From U.S. Centers for Disease Control and Prevention
- U.S. Considers New Tools in Global AIDS Fight (December 16, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The End of AIDS? Could Universal Testing and Treatment End the Epidemic? (Fall 2010)
To read PDF, click here.
In Achieve, from ACRIA and GMHC
- HIV Prevention: A Changing Outlook (Spring 2010)
To read PDF, click here.
In Achieve, from ACRIA and GMHC
- Treatment as Prevention: We've All Heard About It but What Does It Really Mean? (Winter 2010)
In Prevention in Focus: Spotlight on Research and Programming, from Canadian AIDS Treatment Information Exchange
- Q&A: CDC's Clinical Studies of Pre-Exposure Prophylaxis for HIV Prevention: Anticipated Results and Impact (January 26, 2009)
From U.S. Centers for Disease Control and Prevention
- Q&A: CDC's Clinical Studies of Pre-Exposure Prophylaxis for HIV Prevention: Community Involvement in These Studies (January 26, 2009)
From U.S. Centers for Disease Control and Prevention
- Q&A: CDC's Clinical Studies of Pre-Exposure Prophylaxis for HIV Prevention: Safeguards and Services for Trial Participants (January 26, 2009)
From U.S. Centers for Disease Control and Prevention
- Q&A: CDC's Clinical Studies of Pre-Exposure Prophylaxis for HIV Prevention: Trial Designs and Objectives (January 26, 2009)
From U.S. Centers for Disease Control and Prevention
- Q&A: CDC's Clinical Studies of Pre-Exposure Prophylaxis for HIV Prevention: Research Rationale (January 26, 2009)
From U.S. Centers for Disease Control and Prevention
- Antiretroviral Therapy as Pre-Exposure Prophylaxis: A Continuous Vaccine? (Winter 2007/2008)
To read PDF, click here.
In Research Initiative/Treatment Action!, from The Center for AIDS
- Before and After: PrEP and PEP (Summer 2007)
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America
- Q & A: CDC's Clinical Studies of Pre-Exposure Prophylaxis for HIV Prevention (April 2007)
To read PDF, click here.
From U.S. Centers for Disease Control and Prevention
- CDC Trials of Daily Oral Tenofovir for Preventing HIV Infection (December 7, 2005)
[Archived Article]
To read PDF, click here.
From U.S. Centers for Disease Control and Prevention
- What's "The T"? (July/August 2005)
[Archived Article]
An AIDS advocate in Georgia explains why it's important to study tenofovir's potential as an HIV prevention pill.
To read PDF, click here.
In Survival News, from AIDS Survival Project
- CDC's Clinical Studies of Daily Oral Tenofovir for HIV Prevention (June 2005)
[Archived Article]
To read PDF, click here.
From U.S. Centers for Disease Control and Prevention
News & Research
- Risky Business and PrEP Interest in Chicago STI Clinic (January/February 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Concerns Over Using ARV Therapy as Prevention Strategy (January 9, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- UNC HIV Researcher Cohen Discusses His Work, HPTN 052 (January 5, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- British Columbia's "Treatment-as-Prevention Strategy" Helping to Reduce HIV/AIDS Cases, Deaths (January 5, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Treatment as Prevention Is One of the Top Stories of 2011 (December 23, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- HIV Study Named 2011 Breakthrough of the Year by Science (December 22, 2011)
NIH-funded treatment-as-prevention study heralded as a major advance.
From U.S. National Institute of Allergy and Infectious Diseases
- Gilead Seeks First-Ever Approval for Drug to Prevent HIV (December 16, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Gilead Submits Application to FDA Asking for PrEP Approval for Truvada (December 16, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
 Top 10 HIV/AIDS-Related Clinical Developments of 2011 (December 1, 2011)
From The Body
- Pivotal HIV Prevention Trial for Women in Africa Finds That Use of Tenofovir Gel Does Not Prevent HIV: What Does This Mean for HIV Prevention for Women? (November 28, 2011)
Global Campaign for Microbicides statement on the VOICE DSMB decision to discontinue use of tenofovir gel.
From Global Campaign for Microbicides
- NIH Discontinues Tenofovir Vaginal Gel in "VOICE" HIV Prevention Study (November 25, 2011)
Product safe but no more effective than placebo.
From U.S. National Institutes of Health
- VOICE Trial Changes Are Disappointing, Says AVAC; Calls for Continued Research to Find New Prevention Options for Women (November 25, 2011)
To read PDF, click here.
From AIDS Vaccine Advocacy Coalition
- Experts Discuss Treatment as Prevention at USAID-, World Bank-Sponsored Debate (November 14, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Massachusetts Group, Others Push for HIV Prevention Pill (October 25, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
 The Death of the Pariah: A Blog Entry by Jeannie Wraight (October 12, 2011)
"Please, don't let anyone, including yourself, make you feel diseased or contagious or like a threat ever again. HIV science and medicine have come a long way. The stigma we have faced was always wrong and now even more so. Let's bury the pariah."
From The Body
- 96% Campaign Asks Obama to "Pay Attention to Science" and Scale Up Global Access to ARVs (October 10, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Sign On: Treatment Prevents Transmission -- Obama, Stand Up for Treatment Expansion Worldwide (October 7, 2011)
From HIV Prevention Justice Alliance
- What Makes the HPTN 052 Study So Significant? (September/October 2011)
An interview with Myron Cohen, the study's lead author.
In Positively Aware, from Test Positive Aware Network
- Conference Update From IAS 2011: Prevention (September/October 2011)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
 Editor's Note: Back to the Drawing Board (September/October 2011)
"As programs continue to get slashed, doors closed, and positions eliminated, disaster awaits us all if we don't start now to insist on increased funding for treatment education," Jeff Berry writes.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Microbicide Trials Network Stops Tenofovir Arm of Study After Findings Show Drug Less Effective Than Anticipated (September 29, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
 NIH Modifies "VOICE" HIV Prevention Study in Women (September 28, 2011)
Oral tenofovir discontinued in clinical trial.
From U.S. National Institute of Allergy and Infectious Diseases
- California: San Francisco Set to Offer Anti-HIV Pill to Gay Men (September 13, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Preparing for PrEP (September 7, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- ARVs as Prevention: Great Promise and the Questions That Remain (September 2011)
To read PDF, click here.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Preventive Technologies, Immune-Based and Gene Therapies and Research Toward a Cure (September 2011)
In 2011 Pipeline Report, from Treatment Action Group and HIV i-Base
- The iPrEx Results: Lifting Hopes, Raising Questions (Summer/Fall 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Tenofovir/Emtricitabine PreP Shows Protective Effect (Summer/Fall 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- HPTN 052 Study Stopped Early: Significant Reduction in HIV Transmission From Early Use of HIV Treatment in Serodifferent Partners (August 31, 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Groups Press Government for Swift Action on New Prevention Tool (August 30, 2011)
From Black AIDS Institute
- Tenofovir/FTC vs. Tenofovir as Daily Oral PrEP: Preliminary Results From Partners PrEP (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Treatment Is Prevention: ARV Treatment in HPTN-052 Reduces Transmission by at Least 96%: Single Transmission in Treatment Arm Occurred Prior to Viral Suppression (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Forum for Collaborative HIV Research Discusses PrEP (August 25, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
 Treatment Is Prevention Part 1: A Blog Entry by Gary Bell (August 18, 2011)
"As we, as a society, struggle with finding new and creative ways to reduce the transmission of HIV, it was only natural to consider the impact a medical model might have on this challenge. Perhaps one of the most exciting studies within the last several months demonstrates the benefit of immediate, aggressive HIV treatment in reducing transmission."
From The Body
- PrEP Raises Questions Regarding "Risk Disinhibition" and Drug Resistance (August 17, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Guiding Principles for Treatment as Prevention: More Musings from Paul Kawata (August 9, 2011)
From National Minority AIDS Council
- Man Shares Experience of Taking PrEP in Positively Aware (July/August 2011)
From Test Positive Aware Network
- PrEP: Roadmap to the Real World (August 2011)
Establishing the real-world effectiveness of PrEP through demonstration projects.
To read PDF, click here.
From Project Inform
- Models: Tools to Improve Decision Making About HIV (August 1, 2011)
From AIDS.gov
- Encouraging News on the Scientific Front; Moving It Forward to Policy and Programs (July 29, 2011)
From AIDS.gov
- Final iPrEX Analysis Confirms PrEP Effectiveness (July 29, 2011)
From HIVandHepatitis.com
- iPrEx Shows PrEP Is Durable (July 29, 2011)
From HIVandHepatitis.com
- HIV+ Gay and Bi Men! Sign-On Letter Supporting an Informed Debate About PrEP Based on Facts, Not Misinformation (July 29, 2011)
From International Rectal Microbicide Advocates
- PrEP Effective for Heterosexuals, Discordant Couples (July 26, 2011)
From HIVandHepatitis.com
- HIV Prevention -- A Women's Revolution (July 26, 2011)
From HIVandHepatitis.com
- New HIV Prevention Findings Delay Release of WHO Guidelines for Discordant Couples (July 26, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Guidance Needed on Recent HIV Prevention Findings (July 25, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- PrEP in iPrEx: 92 Percent Fewer Infections in Those With Detectable Drug Levels (July 22, 2011)
From AIDSmeds.com
- Gay Men's PrEP Study Final Results: Near 90 Percent Efficacy in Men Who Took Drug, but Adherence Even Lower Than Thought (July 22, 2011)
From aidsmap.com
- Gays: Drug Study Sees Up to 92 Percent Cut in HIV Risk (July 21, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- How PrEP May Impact the African-American Community (July 21, 2011)
From The Root
- Should HIV Meds for HIV-Uninfected People Be a Priority? And Other PrEP Questions: A Blog Entry by Jeannie Wraight (July 21, 2011)
From The Body PRO
- From "What If" to "What Now": Implementing the New Prevention Technologies (July 20, 2011)
From aidsmap.com
- HIV Treatment: It Goes Both Ways (July 20, 2011)
From The Body
- Treatment as Prevention: What Are the Next Steps? (July 20, 2011)
From aidsmap.com
- Clinical Trials Show PrEP Reduces Heterosexual HIV Transmission (July 19, 2011)
In Black AIDS Weekly, from Black AIDS Institute
- HIV Treatment as Prevention: HPTN 052 Offers Proof (July 19, 2011)
From HIVandHepatitis.com
- The Proof Is Here: HIV Treatment Is HIV Prevention (July 19, 2011)
From HIVandHepatitis.com
- PrEP Cuts Sexual HIV Transmissions 62 Percent to 78 Percent in Men and Women (July 19, 2011)
From AIDSmeds.com
- Viral Suppression Reduces HIV Risk Despite More Sex and "Condom Fatigue" in Patients Starting Treatment in Cameroon (July 19, 2011)
From aidsmap.com
- HIV Prevention: Drugs Even More Effective Than Thought (July 19, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- IAS Conference Opens With Push for Treatment as Prevention (July 19, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Pre-Exposure Prophylaxis Does Work for Women, Two Studies Find (July 19, 2011)
From aidsmap.com
 Isn't It Ironic? More Musings from Paul Kawata (July 18, 2011)
From National Minority AIDS Council
- Studies Confirm PrEP, Early ART Prevent HIV Transmission (July 18, 2011)
From HIVandHepatitis.com
- Major AIDS Forum Gets Down to Work Amid Surge of Good News (July 18, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The Research Agenda for Antiretroviral Prevention -- Now It Gets Complex (July 18, 2011)
From aidsmap.com
- Antiretroviral Prevention Methods "Not in Competition" With Each Other (July 17, 2011)
From aidsmap.com
- Julio Montaner, Former IAS President: IAS 2011 a Critical Turning Point for Treatment as Prevention (July 15, 2011)
In IAS 2011 Conference Blog
- Regan Hofmann: Not Drinking the PrEP Kool-AIDS (July 15, 2011)
In POZ
- Elizabeth Pisani: PrEP Makes No Sense for Discordant Couples (July 15, 2011)
In The Wisdom of Whores
- Expand Treatment for Prevention, Experts Urge (July 15, 2011)
From HIVandHepatitis.com
- Medical Breakthroughs Set to Buoy AIDS Council of War (July 15, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Shah Congratulates Researchers on PrEP Findings (July 15, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Where Do We Go From Here: Proof That a Pill Can Prevent HIV in Women and Men (July 14, 2011)
From Global Campaign for Microbicides
- TDF2 Study of Pre-Exposure Prophylaxis (PrEP) Among Heterosexual Men and Women in Botswana: Key Facts (July 14, 2011)
To read PDF, click here.
From U.S. Centers for Disease Control and Prevention
 More Favorable Results on PrEP, But ... (July 14, 2011)
Paul Sax, M.D., questions precisely what the latest encouraging results on PrEP mean in terms of providing antiretrovirals to people in mixed-status relationships.
From Journal Watch
- Project Inform Urges Government Action Following the Positive Results of Two PrEP Studies in Heterosexual Men and Women (July 13, 2011)
From Project Inform
- Open-Label Extension of iPrEx HIV Pre-Exposure Prophylaxis (PrEP) Study Begins at 11 Sites in Six Countries (July 13, 2011)
iPrEx OLE to build on news that PrEP slows HIV infections significantly in both men who have sex with men and heterosexual women and men.
From iprexnews.com
- IAS 2011 Organizers Congratulate Researchers on New Data Showing PrEP Can Reduce Risk of HIV Infection Among Heterosexuals (July 13, 2011)
Trial's results to be presented fully in Rome next week highlight the strength of the conference's scientific programme and critical research advances occurring in HIV.
From International AIDS Society
- Two Major Studies Prove HIV Pre-Exposure Prophylaxis (PrEP) Works in Heterosexual Women and Men; Build on iPrEx Data Showing PrEP Reduces HIV Infections in Men Who Have Sex With Men (July 13, 2011)
From iprexnews.com
- Pivotal Study Finds That HIV Medications Are Highly Effective as Prophylaxis Against HIV Infection in Men and Women in Africa (July 13, 2011)
From University of Washington
 Two New Studies Support Use of PrEP for HIV Prevention Among Heterosexual Men and Women (July 13, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- CDC Trial and Another Major Study Find PrEP Can Reduce Risk of HIV Infection Among Heterosexuals (July 13, 2011)
CDC assessing data from all heterosexual trials to develop interim guidance for use.
From U.S. Centers for Disease Control and Prevention
- Forum in Chicago Explores Truvada's Use in HIV Prevention (June 22, 2011)
In The Windy City Times
- Joint Venture to Manufacture and Distribute Tenofovir Gel in Africa (June 16, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Large Trial of Tenofovir Gel for Women Set to Begin in South Africa (June 15, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
 Study Finds That PReP Acceptance Depends on Cost Instead of Effectiveness: A Blog Entry by Candace Y.A. Montague (June 8, 2011)
"Using consumer marketing techniques, the study found that female sex workers, male-to-female transgender persons and men who have sex with men would be willing to take the pill if the cost to purchase it was low."
From The Body
- Make Antiretroviral Therapy "Cornerstone" of HIV Prevention (June 8, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Ready to Launch: ADAPT Study Looks at Intermittent Dosing of PrEP (June 7, 2011)
From Project Inform
- Immediate Treatment for All of Us? PrEP for Everyone Else? (May 11, 2011)
From Black AIDS Institute
- HIV PJA Strategy Webinar Recap: FEM-PrEP Trial Closure, U.S. Pricing & Access Issues After iPrEx, & UN Update (April 21, 2011)
From HIV Prevention Justice Alliance
- San Francisco Chronicle: Researchers Should Not Give Up Search for HIV Prevention Pill (April 20, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Global Campaign for Microbicides Statement on the Discontinuation of the FEM-PrEP Trial (April 19, 2011)
From Global Campaign for Microbicides
- Researchers to Wind Down HIV Prevention Trial in Women After Interim Results Find Drug Not Offering Protection From HIV (April 19, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Scientists Halt FEM-PrEP Study in Africa (April 18, 2011)
In Housing Works AIDS Issues Update, from Housing Works
- The FEM-PrEP HIV Prevention Study and Its Implications for NIAID Research (April 18, 2011)
From U.S. National Institute of Allergy and Infectious Diseases
- Results of FEM-PrEP Clinical Trial Examining Pre-Exposure Prophylaxis (PrEP) for HIV Prevention Among Heterosexual Women (April 18, 2011)
From U.S. Centers for Disease Control and Prevention
 PrEP Ineffective for Women? Study on Truvada for HIV Prevention Is Unexpectedly Cut Short: A Blog Entry by Myles Helfand (April 18, 2011)
From The Body
- Views From the Front Lines: Pre-Exposure Prophylaxis in Canada (Spring 2011)
Four professionals offer very different perspectives on PrEP in Canada.
In Prevention in Focus: Spotlight on Research and Programming, from Canadian AIDS Treatment Information Exchange
- Preparing for Pre-Exposure Prophylaxis (Spring 2011)
What if a person at risk of HIV infection could take preventative medications regularly before being exposed to HIV to reduce his or her risk of infection? Pre-exposure prophylaxis is beginning to show promise, but it also raises a number of concerns.
In Prevention in Focus: Spotlight on Research and Programming, from Canadian AIDS Treatment Information Exchange
- Act Now: Choice in HIV Prevention -- Let FDA Look at the PrEP Data: A Blog Entry by Julie Davids (March 17, 2011)
From HIV Prevention Justice Alliance
- Like It or Not, PrEP Enters the Clinic (March 11, 2011)
From Journal Watch
- Q and A: Moving PrEP From Promising Trial Result to Practical, Public Health Prevention Intervention? (March 2, 2011)
From HIV Prevention Justice Alliance
- Is PrEP Prevention Justice? (March 1, 2011)
HIV PJA strategy webinar summary.
From HIV Prevention Justice Alliance
- Using Pre-Exposure Prophylaxis (PrEP) as a Prevention Tool for MSM: The Promise Comes With Challenges (February 27, 2011)
From AIDS.gov
 Benefits of Using Antiretroviral Treatment as an Effective Prevention Tool Must Not Be Overlooked (February 23, 2011)
From Black AIDS Institute
- Preventing HIV: New Tools, New Hope (Winter 2010/2011)
To read PDF, click here.
In Achieve, from ACRIA and GMHC
 Wow, That Was Fast: PrEP Guidelines Appear (January 28, 2011)
From Journal Watch
- Interim Guidance: Pre-Exposure Prophylaxis for the Prevention of HIV Infection in Men Who Have Sex With Men (January 28, 2011)
To read PDF, click here.
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
- Doctors Get Guidelines for Medicine to Block HIV (January 28, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- 2011: 10 HIV Stories to Watch, Part 2 (January 26, 2011)
In Black AIDS Weekly, from Black AIDS Institute
- Ethics and the Future of PrEP (January 14, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- MedPage Today Examines Recent Developments, Trials Underway in HIV Prevention (December 24, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Illinois: Project PrEPare, AIDS Foundation of Chicago Hold HIV Drug Forum (December 23, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Utahns Don't Expect Swift Widespread Use of AIDS Pill That Helps Gay Men Avoid HIV Infection (December 22, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Chicago Team Responds to HIV Drug Study (December 17, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Steve Gibson on PrEP: Your Questions Answered (December 16, 2010)
From San Francisco AIDS Foundation
- Promising HIV Prevention Offers Some New Hope (December 14, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- California: Preventive Drug Brings Promise -- and Questions (December 13, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- After HIV Pill News, Now Comes the Tricky Part (December 8, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- iPrEx: A Tenofovir/Emtricitabine Pill a Day Keeps the HIV (Doctor) Away (December 8, 2010)
Part of "Top HIV/AIDS-Related Clinical Developments of 2010," by David Wohl, M.D.
From The Body
- CAPRISA: A Home Run (or at Least a Base Hit) for a Microbicide (December 8, 2010)
Part of "Top HIV/AIDS-Related Clinical Developments of 2010," by David Wohl, M.D.
From The Body
- PrEP: What Does It Mean for Women? (December 8, 2010)
From Global Campaign for Microbicides
- Questions and Answers: Global Pre-Exposure Prophylaxis Initiative (iPrEx) Study (December 8, 2010)
From Global Campaign for Microbicides
- The Role of ARVs in HIV Prevention: Microbicides and PrEP (December 2010)
To read PDF, click here.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Taken Preventively Daily HIV Meds Could Reduce HIV Risk Among Gay, Bisexual Men (November 30, 2010)
From Black AIDS Institute
- Chicago-Based Pre-Exposure Prophylaxis Study Team Responds to Recent iPrEx Study Results (November 29, 2010)
From Project PrEPare
- Hold the Celebrations: Antiretroviral Drugs Not Promised to Prevent HIV: A Blog Entry by Candace Y.A. Montague (November 28, 2010)
"Pills are great and the news of a new potential prevention method is still wonderful. But getting groups of people to see that they are at risk remains to be the challenge."
From The Body
- CDC Statement on Results of iPrEx Trial Examining Pre-Exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex With Men (November 23, 2010)
From U.S. Centers for Disease Control and Prevention
- Global Campaign for Microbicides Lauds Milestone in HIV Prevention Findings That Daily Use of Anti-Retroviral Protects Against HIV Infection (November 23, 2010)
Results from global iPrEx trial offer hope for those at highest risk of infection.
From Global Campaign for Microbicides
- NIH-Funded Study Finds Daily Dose of Antiretroviral Drug Reduces Risk of HIV (November 23, 2010)
From AIDS.gov
- President Obama Welcomes New HIV Prevention Research Results (November 23, 2010)
From AIDS.gov
- The Future of PrEP: Questions and Next Steps Following the iPrEx Study Results (November 23, 2010)
From Project Inform
- Daily Oral Antiretroviral Reduces HIV Infection Risk in MSM by 44%, Study Finds (November 23, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- iPrEx: First-Ever PrEP Efficacy Study Published (November 23, 2010)
Paul Sax, M.D., offers his analysis of the study results and their real-world implications.
From Journal Watch
- Daily Dose of Truvada Reduces HIV Infection Risk by 44 Percent Among Gay Men, Study Finds (November 23, 2010)
From U.S. National Institute of Allergy and Infectious Diseases
- New Lines of Attack in HIV Prevention (November 12, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Systemic Preexposure Prophylaxis for Human Immunodeficiency Virus Infection (October 30, 2010)
In Pharmacotherapy
- Interview With Ernest Hopkins and Bob Grant About Pre-Exposure Prophylaxis (PrEP) (August 6, 2010)
From AIDS.gov
- Study Finds PrEP Is Safe in Gay and Bi Men (July 29, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Study Finds PrEP Is Safe in Gay and Bi Men (July 26, 2010)
From AIDSmeds.com
- Get Prepared for PrEP: "Treatment as Prevention" Moves Ahead (July 26, 2010)
From Black AIDS Institute
- International AIDS Conference Day 5: Dr. Valdiserri Speaks With Dr. Kevin Fenton From the CDC -- A Blog Entry From Positive Policy (July 23, 2010)
In The XVIII International AIDS Conference, from The Body
- Second-Ever Pre-Exposure Prophylaxis Study Reports No Safety Concerns and Promising Result (July 23, 2010)
From aidsmap.com
- Exploring Combination Prevention: the Way Forward (July 23, 2010)
From UNAIDS
- Preliminary Results From First Safety Study of Daily Tenofovir for HIV Prevention Among MSM Find No Significant Concerns (July 23, 2010)
From U.S. Centers for Disease Control and Prevention
- Understanding HIV Transmission Mechanisms: Microbicides and PrEP (July 22, 2010)
To read PDF, click here.
From Henry J. Kaiser Family Foundation
- CDC Study Finds Immune System Benefits of Pre-Exposure Prophylaxis for Animals Infected With the Monkey Form of HIV While Taking These Drugs (July 22, 2010)
From U.S. Centers for Disease Control and Prevention
- Use of Antiretrovirals for Prevention: PrEP, PEP and ART (July 21, 2010)
To read PDF, click here.
From Henry J. Kaiser Family Foundation
- Safety and Effectiveness of 1% Tenofovir Vaginal Microbicide Gel in South African Women: Results of the CAPRISA 004 Trial (July 20, 2010)
To read PDF, click here.
From Henry J. Kaiser Family Foundation
- Statement of Anthony S. Fauci, M.D., Director, NIAID, NIH, on Results From the CAPRISA 004 Microbicide Study (July 19, 2010)
From National Institute of Allergy and Infectious Diseases
- Researchers Present More Findings for Microbicides, PrEP at M2010 Conference (May 25, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- AP Examines HIV Microbicides, PrEP Research (May 18, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Bloomberg Examines Potential Benefits, Drawbacks to PrEP (April 1, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- HIV Treatment May Prevent at Least Nine Out of Ten Transmissions (February 19, 2010)
From aidsmap.com
- Report of a Consultation: Preparing for Pre-Exposure Prophylaxis (PrEP) Results: From Research to Implementation (PDF) (2010)
Meeting was held at the Hotel Victoria-Glion, 29-30 October 2009.
From World Health Organization
- U.S. Health Officials Announce Shift in Focus of PrEP Trial in Botswana (December 18, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Questions and Answers: The VOICE HIV Prevention Study (September 16, 2009)
From U.S. National Institute of Allergy and Infectious Diseases
- Clinical Trial of Antiretroviral-Based HIV Prevention Strategies for Women Now Under Way (September 16, 2009)
From U.S. National Institute of Allergy and Infectious Diseases
- Maraviroc Levels in Female Genital Tract May Support Drug's Potential in HIV Prophylaxis (August 2009)
In Journal of Acquired Immune Deficiency Syndromes
- Prepping for a PrEP Trial (July/August 2009)
Why is it so hard to find young people to participate in HIV-related studies? While trying to find an assistant to help recruit young, gay men for a trial of pre-exposure HIV prophylaxis (PrEP), HIV advocate Keith Green may have stumbled on an answer: homophobia.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Low Bone Mineral Density in Botswana PrEP Trial Participants Raises Concerns (July 24, 2009)
Researchers conducting a trial of tenofovir and emtricitabine as pre-exposure prophylaxis (PrEP) in Botswana have found low bone mineral density levels in HIV-uninfected volunteers at enrollment.
From aidsmap.com
- Antiretrovirals Can Be Used to Prevent Spread of HIV/AIDS, Model Shows (July 21, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- The Promise of Pre-Exposure Prophylaxis (June 1, 2009)
To read PDF, click here.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Herpes Drug Acyclovir Does Not Reduce Risk of HIV Transmission, Does Slow HIV Progression, Study Says (May 14, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Could Isentress (or Other Integrase Inhibitors) Be Used as an HIV Prevention Drug? (April 28, 2009)
From aidsmap.com
- Inter Press Service Examines Research Into PrEP (April 6, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Interview With Myron Cohen, M.D. (March 2009)
To read PDF, click here.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Pre-Exposure Prophylaxis (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- HIV Pre-Exposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes and Cost-Effectiveness (February 26, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Intermittent Oral PrEP May Be as Effective as Daily Oral PrEP for Prevention of Rectal HIV Transmission, Macaque Study Suggests (February 9, 2009)
Gerardo Garcia-Lerma, Ph.D., presents data from a macaque study utilizing a unique method of pre-exposure prophylaxis: oral tenofovir/emtricitabine administered just once prior to exposure, followed by a second dose shortly after exposure.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Topical PrEP Comparison: Tenofovir Alone May Be as Effective as Tenofovir/FTC, Study Finds (February 9, 2009)
Walid Heneine, Ph.D., explains the results of a study in macaques which found that a topical gel offered complete protection against SIV infection -- regardless of whether that gel contained tenofovir alone or tenofovir in combination with emtricitabine.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- ABC News Examines Pre-Exposure Prophylaxis for HIV Prevention (January 22, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- For Post-Exposure HIV Prevention, Viread May Be Gentler Option than Retrovir (April 17, 2008)
From Reuters Health
- New Frontiers in HIV Prevention: Male Circumcision and Pre-Exposure Prophylaxis in the United States -- An Interview at CROI 2007 With Patrick Sullivan, Ph.D., and Lynn Paxton, M.D., M.P.H. (February 27, 2007)
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- HIV Clinical Trial Aiming to Increase Participation of Black MSM (January 11, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Antiretroviral Drugs as Prevention Tools: PEP, PrEP and Prevention for Positives (September 27, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
- PrEP Studies Show Possible Effectiveness; Scientists Say Further Tests Must Be Completed for Confirmation (August 14, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Can a Pill a Day Keep HIV Away? Educators Warn Against Jumping the Gun (May 5, 2006)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Some MSM Already Using Tenofovir as Method of HIV Prevention, Outside of Clinical Trials (December 19, 2005)
[Archived Article]
Physicians and HIV prevention experts say tenofovir has been sold in gay dance clubs around the country and prescribed by some physicians for prevention.
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- We Must Not Let Protestors Derail Trials of Pre-Exposure Prophylaxis for HIV (September 2005)
[Archived Article]
Joep Lange, former president of the International AIDS Society, says the protests reveal a major flaw in global AIDS activism.
In PLoS Medicine
- Family Health International Ends Viread Clinical Trial in Cameroon (August 12, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Family Health International Will Seek Support From Gates Foundation for Tenofovir Trials to Prevent HIV (August 5, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Antiretroviral Drug Researchers, AIDS Advocates Fail to Reach Consensus Over Viread Trials in Developing Countries (May 24, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Fact Sheet on "Project T": A Safety Study of Daily Oral Tenofovir to Prevent HIV Infection in HIV-Negative Men Who Have Sex With Men (PDF) (December 2004)
[Archived Article]
Study sites are in San Francisco and Atlanta.
From San Francisco Department of Public Health
- Alternative HIV Prevention Methods: The World's Most Important AIDS Research? (November 2004)
[Archived Article]
Microbicides and pre-exposure HIV treatment may be easier to develop than vaccines and less controversial than behavioral changes.
To read PDF, click here.
In Project Inform Perspective, from Project Inform
- Regrettably, Cambodia Stops Important Tenofovir Prevention Trial (August 23, 2004)
[Archived Article]
The study's cancellation is a major setback for global HIV prevention efforts, writes AIDS advocate John James.
In AIDS Treatment News, from AIDS Treatment News
- Cambodian Sex Workers Refuse to Participate in Tenofovir HIV Prevention Trial (March 30, 2004)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- "It's OK, I'm on the AIDS Pill" (February 26, 2004)
[Archived Article]
Tenofovir (Viread) is being tested as a "morning-after" pill to prevent HIV infection. But if it's found to work, could it cause more problems than it solves?.
In Wired News
- Tenofovir as Pre-Exposure Prophylaxis (February 2003)
[Archived Article]
From amfAR, The Foundation for AIDS Research
- Prevention: New Approach Will Test Tenofovir for Persons at High Risk (November 22, 2002)
[Archived Article]
A brief analysis of the study's significance for women.
In AIDS Treatment News, from AIDS Treatment News
- $6.5M Set Aside to Study Tenofovir as HIV-Prevention Pill (November 5, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
|
Advertisement
|
Email
Glossary
